- Home
- Publications
- Publication Search
- Publication Details
Title
Sunitinib Possible Sex-Divergent Therapeutic Outcomes
Authors
Keywords
Renal Cell Carcinoma, Brain Tumor, Sunitinib, Renal Cell Carcinoma Patient, Metastatic Brain Tumor
Journal
CLINICAL DRUG INVESTIGATION
Volume 36, Issue 10, Pages 791-799
Publisher
Springer Nature
Online
2016-06-18
DOI
10.1007/s40261-016-0428-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis
- (2015) S. Bracarda et al. ANNALS OF ONCOLOGY
- Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
- (2015) M E Gore et al. BRITISH JOURNAL OF CANCER
- Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment
- (2015) Gökçe Hatipoglu et al. CANCER SCIENCE
- An integrative view on sex differences in brain tumors
- (2015) Tao Sun et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Sunitinib-ibuprofen drug interaction affects the pharmacokinetics and tissue distribution of sunitinib to brain, liver, and kidney in male and female mice differently
- (2015) Christine Li Ling Lau et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The Structure of Clinical Translation:Efficiency, Information, and Ethics
- (2015) Jonathan Kimmelman et al. HASTINGS CENTER REPORT
- A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance
- (2015) Hideyuki Akaza et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib
- (2015) Benjamin Carlisle et al. JNCI-Journal of the National Cancer Institute
- A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib
- (2015) Valerie C Henderson et al. eLife
- Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib
- (2015) Benjamin Carlisle et al. JNCI-Journal of the National Cancer Institute
- The Gender of Cell Lines Matters When Screening for Novel Anti-Cancer Drugs
- (2014) Larissa M. Nunes et al. AAPS Journal
- Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours
- (2014) N A G Lankheet et al. BRITISH JOURNAL OF CANCER
- Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: An overview of the literature
- (2014) Giuseppe Lombardi et al. CANCER TREATMENT REVIEWS
- Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients
- (2014) C. Narjoz et al. INVESTIGATIONAL NEW DRUGS
- Oral Anticancer Drugs: How Limited Dosing Options and Dose Reductions May Affect Outcomes in Comparative Trials and Efficacy in Patients
- (2014) Vinay Prasad et al. JOURNAL OF CLINICAL ONCOLOGY
- Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group
- (2014) B. M. Alexander et al. NEURO-ONCOLOGY
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- The Effect of ABCG2 Genotype on the Population Pharmacokinetics of Sunitinib in Patients With Renal Cell Carcinoma
- (2014) Tomoyuki Mizuno et al. THERAPEUTIC DRUG MONITORING
- Age- and sex-related differences of organic anion-transporting polypeptide gene expression in livers of rats
- (2014) Wei-Yu Hou et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Drug interactions with sunitinib
- (2014) Idoia Bilbao-Meseguer et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration
- (2013) A Bamias et al. BRITISH JOURNAL OF CANCER
- Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide
- (2013) E. I. Zimmerman et al. CLINICAL CANCER RESEARCH
- Sunitinib Treatment for Multiple Brain Metastases from Jejunal Gastrointestinal Stromal Tumor: Case Report
- (2013) Hayato TAKEUCHI et al. NEUROLOGIA MEDICO-CHIRURGICA
- Plasma Concentrations of Tyrosine Kinase Inhibitors Imatinib, Erlotinib, and Sunitinib in Routine Clinical Outpatient Cancer Care
- (2013) Nienke A. G. Lankheet et al. THERAPEUTIC DRUG MONITORING
- Disparities in chronic myeloid leukemia survival by age, gender, and ethnicity in pre- and post-imatinib eras in the US
- (2012) Rakesh Mandal et al. ACTA ONCOLOGICA
- Outcome of Patients With Renal Cell Carcinoma Metastatic to the Brain Treated With Sunitinib Without Local Therapy
- (2012) Zita Dubauskas Lim et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Fatal Liver Failure in a Patient Treated With Sunitinib for Renal Cell Carcinoma
- (2012) Willmosh Mermershtain et al. Clinical Genitourinary Cancer
- Intracranial Metastasis From Pediatric GI Stromal Tumor
- (2012) Jyothi P. Jagannathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib
- (2011) F Di Fiore et al. BRITISH JOURNAL OF CANCER
- OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies
- (2011) Megan Roth et al. BRITISH JOURNAL OF PHARMACOLOGY
- Brain metastases from renal cell carcinoma. Should we change the current standard?
- (2011) Jordi Remon et al. CANCER TREATMENT REVIEWS
- Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: Our experience and review of the literature
- (2011) Yuji Kusuda et al. INTERNATIONAL JOURNAL OF UROLOGY
- Sunitinib in metastatic renal cell carcinoma patients with brain metastases
- (2010) Martin E. Gore et al. CANCER
- ABCC2/Abcc2: a multispecific transporter with dominant excretory functions
- (2010) Katalin Jemnitz et al. DRUG METABOLISM REVIEWS
- Fatal Liver Failure in a Patient on Acetaminophen Treated with Sunitinib Malate and Levothyroxine
- (2009) Amy M Weise et al. ANNALS OF PHARMACOTHERAPY
- Clinical pharmacokinetics of tyrosine kinase inhibitors
- (2009) Nielka P. van Erp et al. CANCER TREATMENT REVIEWS
- Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters
- (2009) S. Hu et al. CLINICAL CANCER RESEARCH
- A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients
- (2009) B. E. Houk et al. CLINICAL CANCER RESEARCH
- Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
- (2009) Youjin Je et al. LANCET ONCOLOGY
- Multifocal Brain Metastases in Clear Cell Renal Cell Carcinoma with Complete Response to Sunitinib
- (2009) Hao Zeng et al. UROLOGIA INTERNATIONALIS
- Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
- (2008) A A M van der Veldt et al. BRITISH JOURNAL OF CANCER
- Tissue Distribution, Gender-Divergent Expression, Ontogeny, and Chemical Induction of Multidrug Resistance Transporter Genes (Mdr1a, Mdr1b, Mdr2) in Mice
- (2008) Y. J. Cui et al. DRUG METABOLISM AND DISPOSITION
- Brain Metastases in Patients With Renal Cell Cancer Receiving New Targeted Treatment
- (2007) Helgi H. Helgason et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now